Park Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$254K Sell
971
-75
-7% -$19.2K 0.13% 148
2026
Q2
$263K Buy
1,046
+98
+10% +$21.1K 0.15% 102
2026
Q1
$206K Sell
948
-28
-3% -$6.21K 0.2% 60
2025
Q4
$223K Buy
976
+7
+0.7% +$1.6K 0.16% 76
2025
Q3
$224K Buy
+969
New +$197K 0.18% 73

Other funds holding ABBV

Park Capital Management's ABBV Position: Q3 2026 in Review

Park Capital Management reduced its AbbVie (ABBV) stake by 7.2% in Q3 2026, selling an estimated $19.2K and leaving 971 shares worth $254K. The position accounts for 0.13% of the portfolio, ranked #148.

Park Capital Management first reported a position in ABBV in Q3 2025 and has held it in 5 quarters since. The position peaked at $263K in Q2 2026. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Park Capital Management held 971 shares of AbbVie worth $254K as of Q3 2026.
  • Park Capital Management sold 75 AbbVie shares in Q3 2026, an estimated $19.2K.
  • AbbVie made up 0.13% of Park Capital Management's portfolio in Q3 2026, its #148 holding.
  • Park Capital Management first reported a position in AbbVie in Q3 2025 and has held it in 5 quarters since.
  • Park Capital Management's AbbVie position peaked at $263K in Q2 2026.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Park Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.